checkAd

    Progressive Care Reports July 2020 Performance Data  120  0 Kommentare $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income - Seite 2

    Weisberg added, “With strong cash levels in place, multiple scalable growth strategies underway, and core trends continuing to support strong expectations for the second half of the year, we believe we are poised to capitalize on opportunities for further growth in the months ahead.”

    *All claims processed for not-for-profit entities are conducted on an agency basis. The gross value of the submissions is excluded from gross sales. Transaction fees due to the Company as a result of these claims are included in gross sales calculations.

    For more information about Progressive Care, please visit the company’s website.

    Connect and stay in touch with us on social media:

    Progressive Care Inc.

    https://www.facebook.com/ProgressiveCareUS/

    https://twitter.com/ProgressCareUS

    PharmCoRx

    https://www.facebook.com/pharmcorx/

    https://twitter.com/PharmCoRx

    About Progressive Care Inc.

    Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

    Cautionary Statement Regarding Forward-Looking Statements

    Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the Company’s performance data for the month of July, 2020 and the Company’s future growth and strategies. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Progressive Care Reports July 2020 Performance Data $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income - Seite 2 MIAMI, FL, Aug. 25, 2020 (GLOBE NEWSWIRE) - via NEWMEDIAWIRE - Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance …